In Australia, 200 children and adolescents are diagnosed with difficult to treat cancers each year, and their chance of survival is less than 30%. The Zero Childhood Cancer project aims to change this with its PRISM trial.
Patients enrolled in the trial have their tumors genetically sequenced to allow for a tailored approach for each child’s treatment. By determining the genetic makeup of the tumors, the hope is doctors can determine exactly which medicine will be most effective; the right drug for the right child at the right time.
A recent philanthropic donation is set to double the number of children who can be enrolled in the PRISM trial from 200 to 400. No child or their cancers are identical. The donation will allow these patients to have a personalized treatment plan that would not otherwise have been available to them.
Source: The Sydney Morning Herald
Read more: http://ow.ly/8ZR750ulBAP